BioMarin will discontinue dosing and enrollment of its phase 2 trials for Voxzogo—currently approved in achondroplasia, a ...

Annualized height velocity of 9.05 cm/year (LS mean) for TransCon hGH-treated children was similar at Week 52 to daily somatropin-treated children - TransCon hGH showed a safety and tolerability ...

BioMarin will stop dosing in Phase II trials of the drug in Turner Syndrome, SHOX-deficiency and Aggrecan deficiency.

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.

I am treating a 4-year-old with Turner syndrome and type 1 diabetes. She has no malformations, her height is 92 cm, and her metabolic control is excellent (HbA1c, 6%). Her parents have been informed ...

APEX, N.C. (WTVD) -- Despite being a pharmacist, Dan Patriss first learned of Turner syndrome after his daughter was diagnosed at 4 years old. It's a genetic condition caused by a missing or altered X ...

Liliana Castaneda, with Turner syndrome, was diagnosed with rare clear cell carcinoma of the vagina at 14, unrelated to her condition. Her treatment involved five chemotherapy rounds, external beam ...

I receive many emails from twins and their families with important stories to tell. In October 2025, I received a message from a fraternal female twin to say that she had a twin sister with Turner ...

March 16 (Reuters) - BioMarin Pharmaceutical will discontinue mid-stage trials of its bone disorder treatment after reports of several cases of patients' hip joint slipping out of place, the drugmaker ...